Clinical Trial Update: Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of liraglutide for obesity in the context of non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Non-alcoholic Fatty Liver Disease, Obesity | Phase 4 | Status: UNKNOWN